Home » Newsletters » BioWorld Asia

BioWorld Asia

June 20, 2001

View Archived Issues

MelTec, Evotec Form Venture For Drug Discovery, Services

Heat-Shock Proteins Suggest New Mode Of Attack On TB

Cyclacel Raises $47.7M For Cell-Cycle Cancer Programs

Meristem Enters Cystic Fibrosis Licensing Agreement With Solvay

Ethypharm Sets Target Of $137M For IPO in France

Parliament Genetics Debate Takes Pro-Industry Direction

Galapagos, Bayer Enter Deal To Discover Protein Functions

Association Seeks More Options For Biotechnology Product Filings

Other News To Note

DeCODE Enters Monoclonal Antibody Deal With Genmab

Zentaris Cites Market Conditions In Postponing IPO In Germany

Oxford Glyco, Marconi Create Venture For Protein Databases

Amaxas Second Round Nets EUR13M For Transfection Work

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...